STOCK TITAN

Milestone Scientific Schedules Second Quarter 2021 Business Update Conference Call

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
Rhea-AI Summary

Milestone Scientific (NYSE American: MLSS) announced a conference call on August 16, 2021, at 11:00 A.M. ET to discuss its second-quarter financial results and corporate developments. The call can be accessed via phone or webcast. An audio replay will be available until August 30, 2021. Milestone Scientific specializes in innovative drug delivery technologies, particularly for painless injections using its proprietary DPS Dynamic Pressure Sensing technology® for various medical applications. For further details, visit their website.

Positive
  • Upcoming conference call to discuss financial results and corporate progress.
  • Innovative technology offering the potential for market differentiation.
Negative
  • No specific financial results shared in the press release may indicate a lack of transparency.
  • -

ROSELAND, N.J., Aug. 11, 2021 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (NYSE American: MLSS), a leading developer of computerized drug delivery instruments that provides virtually painless and precise injections, today announced it will host a conference call at 11:00 A.M. Eastern Time on Monday, August 16, 2021 to discuss the Company’s financial results for the second quarter ended June 30, 2021, as well as the Company’s corporate progress and other developments.

The conference call will be available via telephone by dialing toll free 1- 844-369-8770 for U.S. callers or 862-298-0840 for international callers. A webcast of the call may be accessed at https://www.webcaster4.com/Webcast/Page/2306/42492 or on the Company’s website at https://www.milestonescientific.com/.

An audio replay of the call will be available through August 30, 2021, and can be accessed by dialing 877-481-4010 for U.S callers or 919-882-2331 for international callers and by entering the access code: 42492.        

About Milestone Scientific Inc.

Milestone Scientific Inc. (MLSS) is a biomedical technology research and development company that patents, designs, develops and commercializes innovative diagnostic and therapeutic injection technologies and instruments for medical, dental, cosmetic and veterinary applications. Milestone's computer-controlled systems are designed to make injections precise, efficient, and virtually painless. Milestone’s proprietary DPS Dynamic Pressure Sensing technology® is our technology platform that advances the development of next-generation devices, regulating flow rate and monitoring pressure from the tip of the needle, through platform extensions for local anesthesia for subcutaneous drug delivery, with specific applications for cosmetic botulinum toxin injections, epidural space identification in regional anesthesia procedures and intra-articular joint injections. For more information please visit our website: www.milestonescientific.com.

Contact:
David Waldman or Natalya Rudman
Crescendo Communications, LLC
Email: mlss@crescendo-ir.com
Tel: 212-671-1020


FAQ

When is Milestone Scientific's conference call for Q2 2021 results?

The conference call will take place on August 16, 2021, at 11:00 A.M. ET.

How can I listen to the Milestone Scientific conference call?

You can listen by dialing 1-844-369-8770 for U.S. callers or 862-298-0840 for international callers, or via webcast on their website.

What technology does Milestone Scientific specialize in?

Milestone Scientific specializes in computerized drug delivery instruments designed for virtually painless and precise injections.

What does DPS Dynamic Pressure Sensing technology® do?

DPS Dynamic Pressure Sensing technology® regulates flow rate and monitors pressure during injections in various medical applications.

Milestone Scientific, Inc.

NYSE:MLSS

MLSS Rankings

MLSS Latest News

MLSS Stock Data

63.09M
65.92M
15.5%
5.47%
0.15%
Medical Instruments & Supplies
Orthopedic, Prosthetic & Surgical Appliances & Supplies
Link
United States of America
LIVINGSTON